HPB

SSO/NANETS/AHPBA/SIO Guidelines for Neuroendocrine Tumors Liver Metastases (Non-CME)

Moderator(s)

• 

  Julie Hallet, MD MSc FRCSC FSSO (she/her/hers)

  Associate Professor of Surgery
  University of Toronto
  Toronto, Ontario, Canada
• 

  Aslam Ejaz, MD

  Chief, Division of Surgical Oncology
  University of Illinois at Chicago
  Chicago, Illinois, United States

The management of neuroendocrine tumor (NET) liver metastases is a rapidly evolving field that requires multidisciplinary expertise. In an unprecedented collaboration, the Society of Surgical Oncology (SSO) joined forces with the American Hepato-Pancreato-Biliary Association (AHPBA), the North American Neuroendocrine Tumor Society (NANETS), and the Society of Interventional Oncology (SIO) to develop comprehensive, evidence-based clinical practice guidelines. This session will provide an overview of the recommendations and engage the audience in an interactive discussion with experts directly involved in the guidelines’ development. Participants will gain insights into how these recommendations can be applied to real-world clinical practice to improve patient outcomes.

Presentations:

• 4:16 PM - 4:26 PM MST

  Guidelines Process Overview
  

  Faculty: Daniel A. Anaya, MD, MSHCT – Moffitt Cancer Center
• 4:26 PM - 4:36 PM MST

  Recommendations – Surgical Care
  

  Faculty: James R. Howe, MD – University of Iowa Hospitals and Clinics
• 4:36 PM - 4:46 PM MST

  Recommendations – Integration of Liver-Directed
  

  Faculty: Alexandra Gangi, MD – Cedars Sinai Medical Centre
• 4:46 PM - 4:56 PM MST

  Recommendations – Integration of Systemic Therapies
  

  Faculty: Callisia Clarke, MD, MS (she/her/hers) – Medical College of Wisconsin
• 4:56 PM - 5:15 PM MST

  Illustrative Case Discussion and Q&A